Lack of evidence for human herpesvirus-8 transmission via blood transfusion in a historical US cohort

Journal of Infectious Diseases

Volumn 199, Issue 11, 2009, Pages 1592-1598

  Cannon, Michael J ^a   Operskalski, Eva A ^b   Mosley, James W ^b   Radford, Kay ^a   Dollard, Sheila C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECIPIENT; SEROCONVERSION; SEROLOGY; SEROPREVALENCE; SURGICAL PATIENT; VIRUS TRANSMISSION;

BLOOD DONORS; BLOOD TRANSFUSION; COHORT STUDIES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; REPRODUCIBILITY OF RESULTS; SAFETY;

EID: 66549086379     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/598859     Document Type: Article

References (31)

1. Cannon MJ, Laney AS, Pellett PE. Human herpesvirus 8: current issues. Clin Infect Dis 2003; 37:82-7.
2. Engels EA, Atkinson JO, Graubard BI, et al. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 2007; 196:199-207.
3. Pellett PE, Wright DJ, Engels EA, et al. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 2003; 43:1260-8.
4. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338:948-54.
5. Cannon MJ, Dollard SC, Smith DK, et al. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 2001; 344: 637-43.
6. Engels EA, Eastman H, Ablashi DV, Wilks RJ, Braham J, Manns A. Risk of transfusion-associated transmission of human herpesvirus 8. J Natl Cancer Inst 1999; 91:1773-5.
7. Lefrere JJ, Mariotti M, Girot R, Loiseau P, Herve P. Transfusional risk of HHV-8 infection. Lancet 1997; 350:217-11.
8. Operskalski EA, Busch MP, Mosley JW, Kedes DH. Blood donations and viruses. Lancet 1997; 349:1327-11.
9. Atkinson J, Edlin BR, Engels EA, et al. Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis 2003; 187:974-81.
10. Diamond C, Thiede H, Perdue T, MacKellar D, Valleroy LA, Corey L. Seroepidemiology of human herpesvirus 8 among young men who have sex with men. Seattle Young Men's Survey Team. Sex Transm Dis 2001; 28:176-83.
11. Goedert JJ, Charurat M, Blattner WA, et al. Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. AIDS 2003; 17:425-33.
12. Sosa C, Benetucci J, Hanna C, et al. Human herpesvirus 8 can be transmitted through blood in drug addicts. Medicina (B Aires) 2001; 61:291-4.
13. Dollard SC, Nelson KE, Ness PM, et al. Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort. Transfusion 2005; 45:500-3.
14. Hladik W, Dollard SC, Mermin J, et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006; 355:1331-8.
15. Mbulaiteye SM, Biggar RJ, Bakaki PM, et al. Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. J Natl Cancer Inst 2003; 95:1330-5.
16. Lefrere JJ, Guillaume N, Laperche S. Should cellular therapy products be tested for human herpesvirus 8? Transfusion 2007; 47:1550.
17. Moore PS, Chang Y, Jaffe HW. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2007; 356:88.
18. Serraino D, Piselli P, Scuderi M, et al. Screening for human herpesvirus 8 antibodies in Italian organ transplantation centers. Clin Infect Dis 2005; 40:203-5.
19. Dodd RY. Human herpesvirus-8: what (not) to do? Transfusion 2005; 45:463-5.
20. Hollinger FB, Mosley JW, Szmuness W, et al. Non-A, non-B hepatitis following blood transfusion: risk factors associated with donor characteristics. In: Szmuness W, Alter HJ, Maynard JE, eds. Philadelphia: Franklin Institute Press, 1982; 361-76.
21. Operskalski EA, Mosley JW, Tobler LH, et al. HCV viral load in antiHCV-reactive donors and infectivity for their recipients. Transfusion 2003; 43:1433-41.
22. Mosley JW, Stevens CE, Aach RD, et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995; 35:5-12.
23. Mimms LT, Mosley JW, Hollinger FB, et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 1993; 307:1095-7.
24. Aach RD, Stevens CE, Hollinger FB, et al. Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first- and second-generation assays. N Engl J Med 1991; 325:1325-9.
25. Stevens CE, Aach RD, Hollinger FB, et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients-an analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984; 101:733-8.
26. Busch M, Chamberland M, Epstein J, Kleinman S, Khabbaz R, Nemo G. Oversight and monitoring of blood safety in the United States. Vox Sang 1999; 77:67-76.
27. Stover CT, Smith DK, Schmid DS, et al. Prevalence of and risk factors for viral infections among human immunodeficiency virus (HlV)-infected and high-risk HIV-uninfected women. J Infect Dis 2003; 187:1388-96.
28. Cervia JS, Wenz B, Ortolano GA. Leukocyte reduction's role in the attenuation of infection risks among transfusion recipients. Clin Infect Dis 2007; 45:1008-13.
29. Kleinman SH, Glynn SA, Higgins MJ, et al. The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion. Transfusion 2005; 45:1073-83.
30. Cannon MJ, Dollard SC, Black JB, et al. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS 2003; 17:215-22.
31. Laney AS, Dollard SC, Jaffe HW, et al. Repeated measures study of human herpesvirus 8 (HHV-8) DNA and antibodies in men seropositive for both HHV-8 and HIV. AIDS 2004; 18:1819-26.